1 / 3

Impact of Prior Stroke on Outcomes in the CURE Trial: Insights from Unpublished Data

This analysis explores the outcomes of patients with a history of stroke or TIA in the CURE trial, involving 506 patients without significant interaction for any outcome. It also considers data from 3,495 participants aged 75 or older with a weight of less than 60 kg, revealing no significant interactions. Furthermore, we compare findings to TRITON-TIMI 38, highlighting significant results (P<0.05). These insights, courtesy of Dr. John Eikelboom, contribute to understanding the implications of prior strokes in clinical settings.

deirdre-wilson
Download Presentation

Impact of Prior Stroke on Outcomes in the CURE Trial: Insights from Unpublished Data

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CURE: Prior Stroke or TIA (N=506) No significant interaction for any outcome C=clopidogrel CURE trial (unpublished data) Courtesy of Dr. John Eikelboom

  2. CURE: Prior Stroke, Age ≥75, Weight <60 kg (N=3495) No significant interaction for any outcome CURE trial (unpublished data) Courtesy of Dr. John Eikelboom

  3. CURE and TRITON-TIMI 38: Prior Stroke or TIA *P<0.05 CURE trial (unpublished data) Courtesy of Dr. John Eikelboom; Wiviott et al. N Engl J Med 2007;357(20):2001-15.

More Related